In addition, the acute infusion of recombinant MCP-1 in mice induces systemic insulin resistance without causing macrophage infiltration into AT (142), indicating that MCP-1 can also act as a potent inducer of insulin resistance in addition to its role in AT inflammation. This evidence concerns the gene CCL2 and Insulin resistance.